Dataset Information


Knock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypes.

ABSTRACT: Key neuropathological hallmarks of Alzheimer's disease (AD) are elevated levels of amyloid ?-peptide (A?) species generated via amyloid precursor protein (APP) endoproteolysis and cleavage by the rate-limiting ?-site enzyme 1 (BACE1). Because rodents do not develop amyloid pathologies, we here investigated whether AD-like endophenotypes can be created in mice by expression of human bace1. To avoid pitfalls of existing models, we introduced hbace1 via knock-in under the control of the CaMKII ? promoter into the safe HPRT locus. We report amyloidogenic processing of murine APP in the hBACE1 mice (termed PLB4), resulting in the formation of toxic APP metabolites that accumulate intra- and extraneuronally in hippocampus and cortex. Pronounced accumulation of A?*56 and A? hexamers in the absence of plaque deposition was detected in brain tissue from symptomatic PLB4 mice. Heightened levels of inflammation (gliosis) also appeared in several AD-related brain regions (dentate gyrus, hippocampal area CA1, piriform and parietal cortices) at 6 and 12 months of age. Behaviorally, deficits in habituation to a novel environment and semantic-like memory (social transmission of food preference) were detected from 3 to 4 months of age. Impairments in spatial learning strategies in long-term reference (water maze) and working memory (Y-maze) tasks presented at 6 months, and were distinct from reductions in locomotor activity and anxiety. Overall, our data indicate for the first time that targeted, subtle forebrain-specific expression through single gene knock-in of hBACE1 is sufficient to generate AD-relevant cognitive impairments amid corresponding histopathologies, confirming human BACE as the key parameter in amyloid pathogenesis.

SUBMITTER: Plucinska K 

PROVIDER: S-EPMC4122804 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6541940 | BioStudies
2019-01-01 | S-EPMC6826143 | BioStudies
2017-01-01 | S-EPMC5692556 | BioStudies
2020-01-01 | S-EPMC7489007 | BioStudies
2017-01-01 | S-EPMC5354320 | BioStudies
2020-01-01 | S-EPMC7664057 | BioStudies
2018-01-01 | S-EPMC5796504 | BioStudies
2020-01-01 | S-EPMC7026402 | BioStudies
1000-01-01 | S-EPMC5725092 | BioStudies
2018-01-01 | S-EPMC5908850 | BioStudies